Takeda Pharmaceutical Co Ltd (TAK)
13.28
+0.06
(+0.49%)
USD |
NYSE |
May 20, 16:00
13.28
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Cash from Operations (Quarterly): 1.999B for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.999B |
| December 31, 2023 | 948.05M |
| September 30, 2023 | 1.343B |
| June 30, 2023 | 673.38M |
| March 31, 2023 | 2.389B |
| December 31, 2022 | 2.638B |
| September 30, 2022 | 1.559B |
| June 30, 2022 | 650.14M |
| March 31, 2022 | 3.428B |
| December 31, 2021 | 2.942B |
| September 30, 2021 | 2.110B |
| June 30, 2021 | 1.524B |
| March 31, 2021 | 3.696B |
| December 31, 2020 | 2.147B |
| September 30, 2020 | 2.338B |
| June 30, 2020 | 1.355B |
| March 31, 2020 | 1.708B |
| December 31, 2019 | 1.274B |
| September 30, 2019 | 2.081B |
| June 30, 2019 | 1.099B |
| March 31, 2019 | 1.091B |
| December 31, 2018 | 814.36M |
| September 30, 2018 | 686.11M |
| June 30, 2018 | 371.06M |
| March 31, 2018 | 1.178B |
| Date | Value |
|---|---|
| December 31, 2017 | 726.34M |
| September 30, 2017 | 834.79M |
| June 30, 2017 | 671.11M |
| March 31, 2017 | 1.162B |
| December 31, 2016 | 162.48M |
| September 30, 2016 | 621.96M |
| June 30, 2016 | 470.08M |
| March 31, 2016 | -1.192B |
| December 31, 2015 | 626.87M |
| September 30, 2015 | 623.64M |
| June 30, 2015 | 153.69M |
| March 31, 2015 | 361.45M |
| December 31, 2014 | 493.12M |
| September 30, 2014 | 696.63M |
| June 30, 2014 | 117.83M |
| March 31, 2014 | 1.058B |
| December 31, 2013 | 436.63M |
| September 30, 2013 | 895.35M |
| June 30, 2013 | -904.92M |
| March 31, 2011 | 1.276B |
| December 31, 2010 | 787.48M |
| September 30, 2010 | 1.311B |
| June 30, 2010 | 422.68M |
| March 31, 2010 | 1.116B |
| December 31, 2009 | 965.04M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
650.14M
Minimum
Jun 2022
3.696B
Maximum
Mar 2021
1.895B
Average
1.854B
Median
Cash from Operations (Quarterly) Benchmarks
| Astellas Pharma Inc | 340.83M |
| Nxera Pharma Co Ltd | -14.86M |
| PeptiDream Inc | -12.96M |
| Healios KK | -4.144M |
| AnGes Inc | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -489.35M |
| Cash from Financing (Quarterly) | -450.06M |
| Free Cash Flow | 1.633B |
| Free Cash Flow Per Share (Quarterly) | 0.4637 |
| Free Cash Flow to Equity (Quarterly) | 2.559B |
| Free Cash Flow to Firm (Quarterly) | 1.506B |
| Free Cash Flow Yield | 3.89% |